DUBLIN, April 14, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Digital PCR (dPCR) and qPCR Market by Technology, Product, Application, End User - Global Forecasts to 2021" report to their offering.
The global qPCR and dPCR market is expected to reach USD 4.94 billion by 2021 from USD 3.28 billion in 2016, growing at a CAGR of 8.5% during the forecast period.
Market growth can be attributed to the rising incidences of infectious diseases and genetic disorders (coupled with growing geriatric population that is at greater risk of target diseases as compared to adults); technological advancements; increasing public-private investments, funds, and grants; successful completion of the Human Genome Project, and rise in the number of hospitals and diagnostic centers.
In this report, the global qPCR and dPCR market is segmented on the basis of technology, products and services, applications, and end users. On the basis of technology, the market is further segmented into qPCR and dPCR. On the basis of products and services, the market is further segmented into instruments, reagents, and consumables; software; and services.
Geographically, North America is expected to account for the largest share of the global qPCR and dPCR market in 2016, followed by Europe. Factors such as increase in public and private funding and increasing financial support (in the form of research grants and funding projects) from prominent funding agencies and federal institutions for the R&D of innovative qPCR and dPCR products are driving the qPCR and dPCR market in the North America region.
However, Asia-Pacific (comprising China, India, Japan, and the Rest of Asia-Pacific) is projected to be the fastest-growing region in the qPCR and dPCR market during the forecast period, owing to factors such as increasing focus of global life sciences companies on this region, burgeoning efforts to increase awareness related to gene-based disease diagnosis and treatment, growing public and private support to develop novel qPCR and dPCR technologies, growth in the Indian genomics market, and strengthening cancer research in Japan, among others.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Trends
7 Global qPCR and dPCR Market, By Technology
8 Global qPCR and dPCR Market, By Product and Service
9 qPCR and dPCR Market, By Application
10 qPCR and dPCR Market, By End User
11 qPCR and dPCR Market, By Region
12 Competitive Landscape
13 Company Profiles
- Affymetrix, Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Biomérieux S.A.
- F. Hoffman-LA Roche Ltd.
- Fluidigm Corporation
- Qiagen N.V.
- Raindance Technologies, Inc.
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
For more information visit http://www.researchandmarkets.com/research/6dlkdm/digital_pcr
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets